Literature DB >> 30279577

Updates in advanced prostate cancer 2018.

Andrew J Armstrong1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30279577     DOI： 10.1038/s41391-018-0100-7

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN： 1365-7852            Impact factor:   5.554


× No keyword cloud information.
  4 in total

1.  LINC01006 facilitates cell proliferation, migration and invasion in prostate cancer through targeting miR-34a-5p to up-regulate DAAM1.

Authors:  Enhui Ma; Qianqian Wang; Jinhua Li; Xinqi Zhang; Zhenjia Guo; Xiaofeng Yang
Journal:  Cancer Cell Int       Date:  2020-10-19       Impact factor: 5.722

Review 2.  Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes.

Authors:  Kenneth Omabe; Clément Paris; François Lannes; David Taïeb; Palma Rocchi
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

3.  Oncolytic Adenovirus with SPAG9 shRNA Driven by DD3 Promoter Improved the Efficacy of Docetaxil for Prostate Cancer.

Authors:  Meng Lu; Fu-Kun Wei; Chuang Wu; Zi-Yang Xu; Li-Jun Mao; Dong-Rong Yang
Journal:  J Oncol       Date:  2022-04-30       Impact factor: 4.501

4.  PDZRN4 suppresses tumorigenesis and androgen therapy-resistance in prostate cancer.

Authors:  Peng Jin; Lielin Wu; Gang Zhang; Bo Yang; Bisong Zhu
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.207
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.